Txoj Kev Siv Txoj Kev thiab Kev: Kev Koom Tes, Kev Sib Haum Xeeb thiab Yeej-Yeej
cov khoom

Cov khoom

Ibandronate Sodium CAS: 138844-81-2 Chaw Tsim Khoom Siv

Ibandronate sodium (BONIVA) yog ib qho tshuaj bisphosphonate uas muaj nitrogen uas tiv thaiv osteoclast-mediated pob txha resorption. BONIVA kuj muaj cov khoom xyaw tsis ua haujlwm hauv qab no: lactose monohydrate, povidone, microcrystalline cellulose, crospovidone, purified stearic acid, colloidal silicon dioxide, thiab purified water. Lub ntsiav tshuaj zaj duab xis txheej muaj hypromellose, titanium dioxide, talc, polyethylene glycol 6000, thiab purified water.


Cov Lus Qhia Txog Khoom

Cov Cim Npe Khoom

Daim Ntawv Thov thiab Cov Nyhuv

Ibandronate sodium tau siv los kawm txog nws cov nyhuv rau kev loj hlob thiab ultrastructure ntawm Leishmania thiab Giardia los ntawm kev tsim cov kab sib sau ua ke. Nws kuj tau siv los piav qhia txoj kev uas cov bisphosphonates uas muaj nitrogen (N-BPs) nkag mus rau hauv cytosol thiab inhibit lawv lub hom phiaj molecular. Ibandronate sodium inhibits farnesyl diphosphate synthase (IC50 = 20 nM). Ibandronate sodium kuj yog ib qho tshuaj inhibitor resorption pob txha. Nws tau raug tshawb nrhiav rau hauv vitro anti-tumor teebmeem, xws li apoptosis induction, inhibitor ntawm cell loj hlob, inhibition ntawm invasive behavior, thiab inhibition ntawm angiogenesis thiab rau nws lub luag haujlwm hauv vivo hauv ntau yam mob qog noj ntshav suav nrog mob qog noj ntshav mis thiab prostate.

Qauv Khoom

255(1)
Phau Ntawv Nkauj 276(1)

Khoom Ntim:

194(1)

Cov Lus Qhia Ntxiv:

Kev sau ua ke C9H24NNaO7P2
Kev Ntsuas 99%
Qhov tsos Hmoov dawb
CAS Nr. 138844-81-2
Ntim khoom 25KG
Lub Neej Txee 2 xyoos
Kev Khaws Cia Khaws cia rau qhov chaw txias thiab qhuav
Daim Ntawv Pov Thawj ISO.

  • Yav dhau los:
  • Tom ntej no:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb